PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 257 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,466 | -40.1% | 38,741 | -4.5% | 0.00% | -100.0% |
| Q2 2023 | $539,739 | +11.8% | 40,575 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $482,773 | +59.5% | 41,723 | +12.8% | 0.00% | 0.0% |
| Q4 2022 | $302,717 | +320.4% | 36,978 | +199.9% | 0.00% | – |
| Q3 2022 | $72,000 | +38.5% | 12,330 | +5.9% | 0.00% | – |
| Q2 2022 | $52,000 | -97.2% | 11,640 | -21.6% | 0.00% | -100.0% |
| Q1 2022 | $1,854,000 | +520.1% | 14,852 | +2.3% | 0.00% | +300.0% |
| Q4 2021 | $299,000 | +38.4% | 14,522 | +71.4% | 0.00% | – |
| Q3 2021 | $216,000 | -23.9% | 8,472 | +5.0% | 0.00% | -100.0% |
| Q2 2021 | $284,000 | +10.1% | 8,072 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $258,000 | +109.8% | 7,743 | +64.2% | 0.00% | – |
| Q4 2020 | $123,000 | – | 4,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |